Abstract
AbstractThe in vitro anti-amylase activity of three different starch blockers, anti-amylasetablets derived from legume protein concentrate, was compared with that ofacarbose, a bacterial α -glucoside hydrolase inhibitor also containing anti-amylaseactivity. The potency of each of the starch blocker tablets was approximatelyequal, one tablet containing the same anti-amylase activity as 0.24 mg of acarbose.There was no significant reduction of the blood glucose response when 1, 2, 3, 4 or 10 starch-blocker tablets were given to 4 to 7 normal volunteers 5 min beforea test meal containing 50 g carbohydrate as white bread.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
